Glutaredoxin 2 Protein (Grx2) as an Independent Prognostic Factor Associated with the Survival of Colon Adenocarcinoma Patients.

导出 OA

翻译打印收藏纠错

作者： Marlena,Brzozowa-Zasada ^[1] ; Adam,Piecuch ^[1] ; Karolina,Bajdak-Rusinek ^[2] ; Karolina,Gołąbek ^[3] ; Marek,Michalski ^[4] ; Kamil,Janelt ^[2] ; Natalia,Matysiak ^[1]

作者单位： Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland. ^[1] Department of Medical Genetics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland. ^[2] Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Jordana 19, 41-808 Zabrze, Poland. ^[3] Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.;Zabrze Silesian Nanomicroscopy Centre in Zabrze, Silesia LabMed-Research and Implementation Centre, Medical University of Silesia, 40-055 Katowice, Poland. ^[4]

关键词 ELISA Grx2 S-gluathionylation colon adenocarcinoma glutaredoxins glutathione (GSH)oxidative stress prognostic factor redox balance